KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 130 filers reported holding KYMERA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.03 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,043 | -19.1% | 5,183 | +33.8% | 0.00% | – |
| Q2 2023 | $89,040 | -21.3% | 3,873 | +1.4% | 0.00% | – |
| Q1 2023 | $113,186 | -7.4% | 3,820 | -22.0% | 0.00% | – |
| Q4 2022 | $122,179 | +14.2% | 4,895 | -1.1% | 0.00% | – |
| Q3 2022 | $107,000 | -10.1% | 4,949 | -18.4% | 0.00% | – |
| Q2 2022 | $119,000 | -86.7% | 6,062 | -71.4% | 0.00% | -100.0% |
| Q1 2022 | $897,000 | -30.5% | 21,196 | +4.3% | 0.00% | 0.0% |
| Q4 2021 | $1,290,000 | – | 20,331 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,858,262 | $81,429,842 | 12.61% |
| Aquilo Capital Management, LLC | 782,219 | $10,872,844 | 9.85% |
| BVF INC/IL | 4,739,004 | $65,872,156 | 1.78% |
| Redmile Group, LLC | 1,868,507 | $25,972,247 | 1.24% |
| Artal Group S.A. | 1,805,346 | $25,094 | 1.08% |
| Deer Management Co. LLC | 615,895 | $8,560,941 | 1.04% |
| Avoro Capital Advisors LLC | 3,855,000 | $53,584,500 | 0.84% |
| Rock Springs Capital Management LP | 1,504,351 | $20,910,479 | 0.56% |
| AtonRa Partners | 19,172 | $266,491 | 0.56% |
| Baker Brothers Advisors | 4,750,400 | $66,030,560 | 0.38% |